| Volume: | 113,238,819 |
|---|---|
| Day's Low: | $16.80 |
| 52-wk Low: | $12.75 |
| Previous Close: | $17.23 |
| Dividend: | $0.18 |
| Market Cap: | 136,470,000 |
| Avg Volume: | 58,525,200 |
|---|---|
| Day's High: | $17.30 |
| 52-wk High: | $20.36 |
| Open Price: | $17.30 |
| Yield: | 4.26% |
| P/E (Forward): | 7.76 |
| 4:52 PM | 3/19/2010 | UPDATE: Teva Sees $9.2 Billion Europe Revenue By 2015 Without Deals |
| 12:40 PM | 3/19/2010 | MARKET SNAPSHOT: U.S. Stocks Fall As India Hike, Oil Strikes Nerve |
| 11:19 AM | 3/19/2010 | MARKET SNAPSHOT: U.S. Stocks Turn Lower On Greece, Financials |
| 7:56 AM | 3/19/2010 | EU Panel Backs Marketing Authorization For Nivestim |
| 6:38 PM | 3/17/2010 | Roche CEO Touts Pipeline, Remains Open To More Deals |
| 3:26 PM | 3/17/2010 | EPA To Require Beefed Up Labels For Pet Flea, Tick Products |
| 8:49 AM | 3/17/2010 | UPDATE: Cyprotex '09 Profit Falls As Drugmakers Cut Spending |
| 3/21/2010 | Deadbeat Stock #4: Pfizer (PFE) (Blogging Stocks) |
| 3/20/2010 | The Unusual Suspects (ADBE, AIXG, GME, HAS, BBY, CIEN, LGF, ORCL, OSIP, PALM, SOMX, TEVA, TIF, CSCO, PFE, AMGN, RIMM) (24/7 Wall St) |
| 3/20/2010 | Six Deadbeat Stocks to Clean Out of Your Portfolio (Blogging Stocks) |
| 3/19/2010 | 3M Helps End Dow's Streak (WSJ.com) |
| 3/19/2010 | Stocks Face Quadruple Witching (WSJ.com) |
| 3/19/2010 | These are the right stocks for your retirement accounts. (The Motley Fool) |
| 3/19/2010 | Teva's Ratiopharm Deal Calls For Response From Sandoz, Not Pfizer (WSJ.com) |
| 3/19/2010 | Inside Wall Street: Resverlogix Is a Baby Biotech That Could Grow Up Fast (DailyFinance) |
| Most Recent Quarter ($) | Same Quarter Last Year ($) | % Change | |
| EPS, Pro Forma | 0.49 | 0.65 | -24.62 |
| EPS, GAAP | 0.07 | 0.04 | 75.00 |
| Consensus Estimate | 0.49 | 0.60 | -18.33 |
| Trailing 12 Months | Year-Earlier Period | % Change | |
| EPS, Pro Forma | 2.02 | 2.02 | 0.00 |
| EPS, GAAP | 1.24 | 1.20 | 3.33 |
| Consensus Estimate | 1.91 | NA | NA |
| PFE | Industry Average | |
| P/E (TTM) | 13.64 | 13.10 |
| P/E (Forward) | 7.76 | 13.30 |
| PEG Ratio | 3.71 | 1.56 |
| Price/Sales | 2.38 | 2.64 |
| Beta | 0.70 | 0.71 |